| Literature DB >> 25652898 |
Davide Staedler1, Solène Passemard1, Thibaud Magouroux2, Andrii Rogov2, Ciaran Manus Maguire3, Bashir M Mohamed3, Sebastian Schwung4, Daniel Rytz4, Thomas Jüstel5, Stéphanie Hwu2, Yannick Mugnier6, Ronan Le Dantec6, Yuri Volkov7, Sandrine Gerber-Lemaire1, Adriele Prina-Mello7, Luigi Bonacina8, Jean-Pierre Wolf2.
Abstract
Bismuth Ferrite (BFO) nanoparticles (BFO-NP) display interesting optical (nonlinear response) and magnetic properties which make them amenable for bio-oriented diagnostic applications as intra- and extra membrane contrast agents. Due to the relatively recent availability of this material in well dispersed nanometric form, its biocompatibility was not known to date. In this study, we present a thorough assessment of the effects of in vitro exposure of human adenocarcinoma (A549), lung squamous carcinoma (NCI-H520), and acute monocytic leukemia (THP-1) cell lines to uncoated and poly(ethylene glycol)-coated BFO-NP in the form of cytotoxicity, haemolytic response and biocompatibility. Our results support the attractiveness of the functional-BFO towards biomedical applications focused on advanced diagnostic imaging. FROM THE CLINICAL EDITOR: Bismuth Ferrite nanoparticles (BFO-NP) have been recently successfully introduced as photodynamic tools and imaging probes. However, how these nanoparticles interact with various cells at the cellular level remains poorly understood. In this study, the authors performed in vitro experiments to assess the effects of uncoated and PEG-coated BFO-NP in the form of cytotoxicity, haemolytic response and biocompatibility.Entities:
Keywords: Biocompatibility; Bismuth ferrite; Nanophotonic; Non-linear imaging; PEGylation
Mesh:
Substances:
Year: 2015 PMID: 25652898 DOI: 10.1016/j.nano.2014.12.018
Source DB: PubMed Journal: Nanomedicine ISSN: 1549-9634 Impact factor: 5.307